WuXi AppTec IPO tops $353m

By Melissa Fassbender

- Last updated on GMT

(Image: WuXi AppTec Co., Ltd.)
(Image: WuXi AppTec Co., Ltd.)
The Chinese contract research and development company WuXi AppTec has raised more than $353m in its initial public offering of common stock on the Shanghai Stock Exchange.

WuXi AppTec's​ initial public offering (IPO) of 104,198,600 shares of common stock was offered on the Shanghai Stock Exchange​ at RMB21.60 per share.

This, equivalent to US$3.39 per share, means the IPO has brought in more than $353m.

According to the company, the funds will be used to build and expand its R&D facilities in China, “further strengthening its capabilities and capacities to better serve global customers and partners.”

The Shanghai-headquartered CDMO operates 26 sites globally and branch offices in China, the US, Germany, UK, Japan, Korea, and Israel. 

Dr. Ge Li, chairman and CEO of WuXi AppTec, said in a statement: "I'm deeply grateful for the great confidence and support we have received from the investment community… It allows us to further focus on our mission and accelerate growth of our enabling platform.”

WuXi AppTec has not responded to a request for comment as of publication.

Related news

Show more

Related products

show more

Are You Prepared to Meet the New FDA Guidelines?

Are You Prepared to Meet the New FDA Guidelines?

Elligo Health Research® | 23-Mar-2023 | Insight Guide

On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants...

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

Related suppliers

Follow us

Products

View more

Webinars